is wegovy or tirzepatide better for weight loss Weight-loss meds go head-to-head in new study. One was significantly more effective, drugmaker says The Science Behind Mounjaro and

Role of the ERO1-PDI interaction in oxidative protein folding and disease

Joining support groups and getting advice from people going through the same difficulties can be calming due to knowing you are not alone

In the ALF model group, the structure of the liver tissue was disordered and the hepatocytes were necrotic

Some options are GLP-1 medications with different active ingredients or dosing schedules

Access this article References Schweitzer JS, Song B, Herrington TM, Park TY, Lee N, Ko S

In adult placebo-controlled clinical trials across the approved adult populations from baseline to endpoint, CYMBALTA treatment was associated with mean increases of 0.5 mm Hg in systolic blood pressure and 0.8 mm Hg in diastolic blood pressure compared to mean decreases of 0.6 mm Hg systolic and 0.3 mm Hg diastolic in placebo-treated patients